343: Turbulence at the FDA, Bluebird Bio's sale and young biotech VCs
The Readout Loud
00:00
Impact of FDA Meeting Cancellation on Flu Vaccine Development
This chapter examines the implications of the FDA cancelling a vital flu vaccine advisory committee meeting, which is essential for deciding on flu strains for vaccines. The cancellation raises significant concerns amid recent health challenges, including a measles outbreak and the U.S. distancing from the WHO.
Transcript
Play full episode
